Abstract
The article describes synthesis, characterization (NMR, FT-IR, microanalysis, X-ray crystallography), and in vitro anticancer activity of para-xylyl linked bis-benzimidazolium salts and respective dinuclear Ag–NHC complexes. All the compounds were tested for their cytotoxicity against human colorectal cancer (HCT 116) and promyelocytic leukemia (HL-60) cell lines. According to cell viability measurements using MTT assay, all tested compounds showed dose-dependent cytotoxic activity against both cell lines. The tested compounds demonstrated significant activity with IC50 values range 0.01–18.7 μM for HCT 116 and 0.7–55.7 μM for HL-60 cells. 5-Fluorouracil was used as standard drug (IC50 19.2 μM for HCT 116 and 5.4 μM for HL-60). We found that as the size of N-alkyl substitution on benzimidazolium salt increases its cytotoxicity decreases whereas a reverse occurred in case of respective complexes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
